Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
Hosted on MSN8h
Moderna Reports Another Quarterly LossModerna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for canceled manufacturing contract. Goldman Sachs US Biotechnology Analyst Salveen Richter ...
Goldman Sachs CEO David Solomon was awarded an $80 million stock bonus to stay at the helm for another five years, a stark turnaround for a leader whose survival was questioned after the firm's ...
Tightened U.S. sanctions on Moscow have disrupted a roaring trade in discounted Russian oil to China and India, reviving ...
Wall Street got off to a mixed start on Friday after Donald Trump announced new "reciprocal tariffs" on a number of America's ...
Hedge fund giant Bridgewater Associates placed a new bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron Technology and banking giant Goldman Sachs. The latest 13-F filing ...
The world’s biggest hedge fund made a fresh bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron Technology and banking giant Goldman Sachs.
Moderna's Q4 earnings due Feb 14: analysts predict revenue decline & $2.73 loss. Explore vaccine demand, pipeline prospects, and stock outlook.
Moderna (NASDAQ:MRNA – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($2.
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
Star portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...
Goldman Sachs warned there's a risk of a 5% slump in US stocks because ... retreated after President Trump imposed an additional 10% tariff on Chinese goods. Moderna (MRNA) closed down more than -7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results